Is Daulat Securitie overvalued or undervalued?
As of October 17, 2025, Daulat Securitie is considered very expensive and overvalued due to poor profitability metrics, including a PE Ratio of -22.98 and an EV to EBITDA of -13.37, especially when compared to peers like Bajaj Finance and Life Insurance, despite a recent short-term stock return of 6.41%.
As of 17 October 2025, the valuation grade for Daulat Securitie has moved from risky to very expensive. This indicates a significant shift in the company's perceived value, leading to the conclusion that it is overvalued. Key ratios such as the PE Ratio of -22.98, EV to EBITDA of -13.37, and ROE of -3.56% further support this assessment, highlighting the company's poor profitability and negative earnings.In comparison to its peers, Daulat Securitie's valuation metrics stand out unfavorably. For instance, Bajaj Finance has a PE Ratio of 38.21 and EV to EBITDA of 20.25, while Life Insurance boasts a more attractive PE of 11.49 and EV to EBITDA of 8.94. These comparisons illustrate that Daulat Securitie is not only overvalued relative to its peers but also lacks the financial performance to justify its current price. Despite a recent 1-week stock return of 6.41%, which outperformed the Sensex's 1.76%, the longer-term performance shows a concerning decline, with a year-to-date drop of 24.61% compared to the Sensex's gain of 7.44%.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
